Robert E. Conway, Director at ALPINE IMMUNE SCIENCES, INC. (ALPN), sold 15,000 shares at $10.08 ($151K) on 2021-09-23, disclosed to the SEC on 2021-09-27.
Scheduled sale ($151k) by Director.
Nothing distinguishes this filing.
| Filing → |
| ABIO | BUY | 2021-05-13 | $32K | — | Filing → |
| ABIO | BUY | 2021-05-06 | $32K | — | Filing → |
| ABIO | BUY | 2020-12-21 | $42K | — | Filing → |